Onderneming RegeneRx Biopharmaceuticals Inc OTC Bulletin Board
Aandelen
Farmaceutische producten
Vakgebied
Verkoop per activiteit
USD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Novel Molecules
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -.--% |
Verkoop per regio
USD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -.--% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 86 | 13-05-82 | |
J. Finkelstein
CEO | Chief Executive Officer | 72 | 01-01-84 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
J. Finkelstein
CEO | Chief Executive Officer | 72 | 01-01-84 |
Founder | 86 | 13-05-82 | |
Joe McNay
BRD | Director/Board Member | 90 | 01-01-02 |
Mauro Bove
BRD | Director/Board Member | 69 | 01-01-04 |
R. Elsey
BRD | Director/Board Member | 71 | 01-09-10 |
Director/Board Member | 66 | 01-04-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 496 966 | 836 249 ( 55,86 %) | 0 | 55,86 % |
Bedrijfsgegevens
RegeneRx Biopharmaceuticals, Inc.
15245 Shady Grove Road Suite 470
20850, Rockville
+
http://www.regenerx.com![Adres RegeneRx Biopharmaceuticals Inc](https://cdn.zonebourse.com/static/address/7070494.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,52% | 92,1 mld. | |
-3,16% | 37,92 mld. | |
-12,49% | 32,97 mld. | |
+74,90% | 27,92 mld. | |
-11,82% | 16,14 mld. | |
-0,16% | 14,1 mld. | |
-11,18% | 11,66 mld. | |
+171,57% | 10,29 mld. | |
-50,45% | 9,99 mld. |